Neuroprotective, anesthetic, and cardiovascular effects of the NMDA antagonist, CNS 5161A, isoflurane-anesthetized lambs

Anesthesiology

Volumn 93, Issue 1, 2000, Pages 202-208

  Bokesch, Paula M ^a   Kapural, Miranda ^a   Drummond Webb, Jonathan ^a   Baird, Kevin ^a   Kapural, Leo ^a   Mee, Roger B B ^a   Trapp, Bruce ^a   Starr, Norman J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiopulmonary bypass; Immunohistochemistry; In situ hybridization; Minimum alveolar concentration; N methyl D aspartate

Indexed keywords

CNS 5161A; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; HEART ARREST; HEART OUTPUT; HEART RATE; IMMUNOHISTOCHEMISTRY; LAMB; MINIMUM LUNG ALVEOLUS CONCENTRATION; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC VASCULAR RESISTANCE;

EID: 0033946065     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200007000-00031     Document Type: Article

References (37)

1. Weiss J, Goldberg MP, Choi DW: Ketamine protects cultured neocortical neurons from hypoxic injury. Brain Res 1986; 380:186-90
2. Ozyurt E, Graham DI, Woodruff GN, McCulloch J: Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cerebr Blood Flow Metab 1988; 8:138-43
3. Bokesch PM, Seirafi PA, Warner KG, Marchand JE, Kream RM, Trapp RM. Differential immediate-early gene expression in ovine brain after cardiopulmonary bypass and hypothermic circulatory arrest. ANESTHESIOLOGY 1998; 89:961-8
4. Bokesch PM, Halpin DP, Ranger WR, Drummond-Webb JJ, Marchand JE, Bronson RT, Warner KG, Kream RM: Immediate-early gene expression in ovine brain after hypothermie circulatory arrest: Effects of aptiganel. Ann Thorac Surg 1997; 64:1082-8
5. Church J, Zeman S, Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. ANESTHESIOLOGY 1988; 69:702-9
6. Greenamyre JT, Porter RHP: Anatomy and physiology of glutamate in the CNS. Neurology 1994; 44:S7-13
7. Choi DW: Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988; 11:465-9
8. Choi DW: Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7:369-79
9. Rothman SM, Olney JW: Glutamate and the pathophysiology ot hypoxic-ischemic brain damage. Ann Neurol 1986; 19:105-11
10. Kuroda Y, Strebel S, Rafferty C, Bullock R: Neuroprotective doses of NMDA receptors antagonists profoundly reduces the MAC of isoflurane in rats. Anesth Analg 1993; 77:795-800
11. Daniell LC: The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol Biochem Behavior 1990; 36:111-5
12. Ishizaki K, Yoshida N, Yoon MH, Sudoh M, Fujita T: Intrathecally administered NMDA receptor antagonists reduce the MAC of isoflurane in rats. Can J Anesth 1996; 43;724-30
13. Ishizaki K, Yoon DM, Yamazaki M, Arai K, Fujita T: Intrathecal administration of N-methyl-D-aspartate receptor antagonist reduces the minimum alveolar anesthetic concentration of isoflurane in rats. Br J Anesth 1995; 75:636-8
14. Mantz J, Cheramy A, Thierry AM, Glowinski J, Desmonts JM: Anesthetic properties of riluzole (54272 RP), a new inhibitor of glutamate neurotransmission. ANESTHESIOIOGY 1992; 76:844-8
15. Coderre T, Empel IV: The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I: Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 1994; 59:342-52
16. Waxman K, Shoemaker WC, Lippman M: Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg 1980; 58:355-8
17. Hurstveit O, Maurset A, Oye I: Interaction of the chiral forms of ketamine with opioid, phencyclidine, σ and muscarininc receptors. Pharmacol Toxicol 1995; 77:355-9
18. Muir KW, Grosset DG, Lees KR: Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers. Clin Neuropharmacol 1997; 20:311-21
19. Albers GW, Atkinson RP, Kelly RE, Rosenbaum DM: Safety, tolerability and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrophan in patients with acute stroke. Stroke 1995; 26:254-8
20. Conroy BP, Black D, Lin CY, Jenkins LW, Crumrine RC, DeWitt DS, Johnston WE: Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass. ANESTHESIOLOGY 1999; 90:844-54
21. Quasha LA, Eger EI II, Tinker JH: Determination and applications of MAC. ANESTHESIOLOGY 1980; 53:315-34
22. Feerick AE, Johnston WE, Jenkins LW, Lin Cy, Mackay JH, Prough DS: Hyperglycemia during hypothermie canine cardiopulmonary bypass increases cerebral lactate. ANESTHESIOLOGY 1995; 82:512-20
23. Bokesch PM, Marchand JE, Connelly CS, Wurm WH, Kream RM: Dextromethorphan inhibits ischemia-induced c-FOS expression and delayed neruonal death in hippocampal neurons. ANESTHESIOLOGY 1994; 81:470-7
24. Marchand JE, Zaccheo TS, Connelly CS, Kream RM: Selective in situ hybridization histochemical analyses of alternatively spliced mRNAs encoding beta-and gamma-preprotachykinins in rat central nervous system. Mol Brain Res 1993; 17:83-94
25. Crittendon MD, Roberts CS, Rosa L, Vatsia SK, Katz D, Clark RE, Swain JA: Brain protection during circulatory arrest. Ann Thorac Surg 1991; 52:942-7
26. Friesen RH, Lichtor L: Cardiovascular effects of inhalational induction with isoflurane in infants. Anesth Analg 1983; 62:411-4
27. Cook DR, Brandon BW, Shiu G, Wolfson B: The inspired median effective dose, brain concentration at anesthesia, and cardiovascular index for halotane in young rats. Anesth Analg 1981; 60:182-5
28. Salem MR, Bennett EJ, Schweiss JF, Baraka A, Dalal FY, Collins VJ: Cardiac arrest related to anesthesia: Contributing factors in infants and children. JAMA 1975; 233:238-41
29. Wear R, Scott R, Gregory GA: The effects of halothane on the baroresponse of adult and baby rabbits. ANESTHESIOLOGY 1982; 56: 188-91
30. Pearce RA: Volatile anesthetics enhancement of paired-pulse depression investigated in the rat hippocampus in vitro. J Physiol 1996; 492:823-40
31. Tweed WA, Minuck M, Mymin D: Circulatory response with ketamine anesthesia. ANESTHESIOLOGY 1975; 37:613-9
32. Legault C, Furberg CD, Wagenknecht LY, Rogers AT, Stump DA, Coker L, Troost BT, Hammon JW: Nimodipine neuroprotection in cardiac valve replacement: Report of an early terminated trial. Stroke 1996; 27:593-8
33. Nussmeier N, Arlund C, Slogoff S: Neuropsychiatric complications after cardiopulmonary bypass: Cerebral protection by a barbiturate. ANESTHESIOLOGY 1986; 64:165-70
34. Roach GW, Newman MF, Murkin JM, Martzke J, Ruskin A, Li J, Guo A, Wisniewski A, Mangano DT: Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. ANESTHESIOLOGY 1999; 90:1255-64
35. Bullock R, Graham DI, Chen M-H, Lowe D, McCulloh J: Focal cerebral ischemia in the cat: Pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cerebr Blood Flow Metab 1990; 10:669-74
36. Park CK, Nehis DG, Graham DI, Teasdale GM, McCulloch J: Focal cerebral ischemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cerebr Blood Flow Metab 1988; 8:757-62
37. Dyker AG, Edwards KR, Fayad PB, Hormes JT, Lees KR: Safety and tolerability of aptiganel hydrochloride in patients with an acute ischemic stroke. Stroke 1999; 30:2038-42